Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis

Journal of Interferon and Cytokine Research

Volumn 31, Issue 7, 2011, Pages 575-587

  Berghmans, Nele ^a   Nuyts, Amber ^a   Uyttenhove, Catherine ^b   Van Snick, Jacques ^b   Opdenakker, Ghislain ^a   Heremans, Hubertine ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ANIMALS; ANTIBODIES, BLOCKING; CELL COUNT; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; TH1 CELLS; TH1-TH2 BALANCE; TH17 CELLS;

MUS;

EID: 79960110182     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0137     Document Type: Article

References (50)

1. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910-1914. (Pubitemid 36801431)
2. Aggarwal S, Gurney AL. 2002. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 71:1-8. (Pubitemid 34062767)
3. Axtell RC, Xu L, Barnum SR, Raman C. 2006. CD5-CK2 binding/activation- deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol 177:8542-8549. (Pubitemid 44893816)
4. Bettelli E, Oukka M, Kuchroo VK. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345-350. (Pubitemid 46745409)
5. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-g. J Immunol 140:1506-1510.
6. Bocek P, Jr., Foucras G, Paul WE. 2004. Interferon gamma enhances both in vitro and in vivo priming of CD4 T cells for IL-4 production. J Exp Med 199:1619-1630. (Pubitemid 38821995)
7. Brown AM, McFarlin DE. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest 45:278-284. (Pubitemid 11000173)
8. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116:1317-1326.
9. Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB. 2007. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 56:1145-1151. (Pubitemid 46608639)
10. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177:1416-1420. (Pubitemid 44092473)
11. Dijkmans R, Martens E, Beuken E, Cornette F, Dillen C, Heremans H, Boraschi D, Billiau A. 1991. Murine interferon-g/interleukin-1 fusion protein used as antigens for the generation of hybridomas producing monoclonal anti-interleukin-1 antibodies. Cytokine 3:134-140.
12. Dijkmans R, Volckaert G, Van Damme J, De Ley M, Billiau A, De Somer P. 1985. Molecular cloning of murine interferon gamma (MuIFN-g) cDNA and its expression in heterologous mammalian cells. J Interferon Res 5:511-520. (Pubitemid 15236867)
13. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. 1996. Mice with a disrupted IFN-g gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156(1):5-7.
14. Gijbels K, Brocke S, Abrams JS, Steinman L. 1995. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous sytem and circulation. Mol Med 1(7):795-805. (Pubitemid 3013088)
15. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 119:61-69.
16. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. 2005. Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132. (Pubitemid 41541790)
17. Heremans H, Dijkmans R, Sobis H, Vandekerckhove F, Billiau A. 1987. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J Immunol 138:4175-4179. (Pubitemid 17090383)
18. Heremans H, Dillen C, Groenen M, Martens E, Billiau A. 1996. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against IFN-g. Eur J Immunol 26:2393-2398. (Pubitemid 26340941)
19. Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. 1990. Interferon-g, a mediator of lethal lipopolysaccharideinduced Shwartzman-like shock reactions in mice. J Exp Med 171:1853-1869. (Pubitemid 20200228)
20. Hofstetter HH, Forsthuber TG. 2010. Kinetics of IL-17-and interferon-gamma-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice. Neurosci Lett 476:150-155.
21. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237:123-130. (Pubitemid 43117208)
22. Irmler IM, Gajda M, Brauer R. 2007. Exacerbation of antigeninduced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 179:6228-6236.
23. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 T helper cells. Cell 126:1121-1133. (Pubitemid 44380299)
24. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573. (Pubitemid 43939170)
25. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Backstrom BT, Sobel RA, Wucherpfennig KW, Strom TB, Oukka M, Kuchroo VK. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 3:423-431. (Pubitemid 46559831)
26. Krakowski M, Owens T. 1996. Interferon-g confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26(7):1641-1646. (Pubitemid 26230015)
27. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205:1535-1541. (Pubitemid 351962016)
28. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-240. (Pubitemid 40189432)
29. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. 2002. Genemicroarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508. (Pubitemid 34546753)
30. Lublin FD, Knobler RL, Kalman B, Goldhaber M, Marini J, Perrault M, DImperio C, Joseph J, Alkan SS, Korngold R. 1993. Monoclonal anti-g interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16:264-374.
31. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799-810. (Pubitemid 351549879)
32. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5:101-104. (Pubitemid 29186827)
33. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, McClanahan TK, OShea JJ, Cua DJ. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10:314-324.
34. Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB, Wong CH, Schneider E, Dy M, Leite-de-Moraes MC. 2007. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204:995-1001. (Pubitemid 46798144)
35. Momcilovic M, Miljkovic Z, Popadic D, Miljkovic D, Mostarica-Stojkovic M. 2008. Kinetics of IFN-gamma and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats. Neurosci Lett 447:148-152.
36. Murphy AC, Lalor SJ, Lynch MA, Mills KH. 2010. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24:641-651.
37. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ. 2003. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951-1957. (Pubitemid 38032126)
38. OConnor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC, Anderton SM. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 181:3750-3754.
39. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-1141. (Pubitemid 41541791)
40. Roark CL, Simonian PL, Fontenot AP, Born WK, OBrien RL. 2008. Gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20:353-357.
41. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193-1200. (Pubitemid 20343220)
42. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-189. (Pubitemid 38174573)
43. Steinman L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-145.
44. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14:337-342. (Pubitemid 351347910)
45. Suryani S, Sutton I. 2007. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J Neuroimmunol 183:96-103. (Pubitemid 46204914)
46. Tagawa Y, Sekikawa K, Iwakura Y. 1997. Suppression of concanavalin A-induced hepatitis in IFN-g-/-mice, but not in TNF-a-/-mice. J Immunol 159:1418-1428.
47. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172: 146-155. (Pubitemid 351186376)
48. Uyttenhove C, Van Snick J. 2006. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 36:2868-2874. (Pubitemid 44782560)
49. Willenborg DO, Fordham S, Bernard CCA, Cowden WB, Ramshaw IA. 1996. IFN-g plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157(8):3223-3227. (Pubitemid 126449130)
50. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350-352.